Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 39 of the 96 sources its claims cite were checked for support.

Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis

Abstract

OBJECTIVE: The role of the brain-gut axis is of increasing interest in IBD, as the link between common mental disorders and GI inflammation may be bidirectional. We performed a systematic review examining these issues. DESIGN: We searched EMBASE Classic and EMBASE, Medline, and APA PsychInfo (to 11 July 2021) for longitudinal follow-up studies examining effect of symptoms of anxiety or depression on subsequent adverse outcomes in IBD, or effect of active IBD on subsequent development of symptoms of anxiety or depression. We pooled relative risks (RRs) and HRs with 95% CIs for adverse outcomes (flare, escalation of therapy, hospitalisation, emergency department attendance, surgery or a composite of any of these) according to presence of symptoms of anxiety or depression at baseline, or RRs and HRs with 95% CIs for new onset of symptoms of anxiety or depression according to presence of active IBD at baseline. RESULTS: We included 12 separate studies, recruiting 9192 patients. All 12 studies examined brain-to-gut effects. Anxiety at baseline was associated with significantly higher risks of escalation of therapy (RR=1.68; 95% CI 1.18 to 2.40), hospitalisation (RR=1.72; 95% CI 1.01 to 2.95), emergency department attendance (RR=1.30; 95% CI 1.21 to 1.39), or a composite of any adverse outcome. Depression at baseline was associated with higher risks of flare (RR=1.60; 95% CI 1.21 to 2.12), escalation of therapy (RR=1.41; 95% CI 1.08 to 1.84), hospitalisation (RR=1.35; 95% CI 1.17 to 1.57), emergency department attendance (RR=1.38; 95% CI 1.22 to 1.56), surgery (RR=1.63; 95% CI 1.19 to 2.22) or a composite of any of these. Three studies examined gut-to-brain effects. Active disease at baseline was associated with future development of anxiety or depression (RR=2.24; 95% CI 1.25 to 4.01 and RR=1.49; 95% CI 1.11 to 1.98, respectively). CONCLUSION: Bidirectional effects of the brain-gut axis are present in IBD and may influence both the natural history of the disease and psychological health.

Overview

CoChat Summary

## TL;DR

This systematic review and meta-analysis found bi-directional brain-gut axis effects in inflammatory bowel disease (IBD): baseline anxiety or depression predicted worse later IBD outcomes, and active IBD predicted later anxiety or depression. The review included 13 longitudinal studies (12 separate populations) and 9192 patients.

## Key findings

  • The search identified 17,928 citations; 124 were reviewed in full, and 13 eligible articles reported on 12 separate study populations with 9192 patients.
  • In brain-to-gut analyses, baseline anxiety was associated with higher risks of escalation of therapy (RR 1.68; 95% CI 1.18-2.40), hospitalisation (RR 1.72; 95% CI 1.01-2.95), emergency department attendance (RR 1.30; 95% CI 1.21-1.39), and a composite outcome (RR 1.21; 95% CI 1.08-1.36).
  • Baseline depression was associated with higher risks of flare (RR 1.60; 95% CI 1.21-2.12), escalation of therapy (RR 1.41; 95% CI 1.08-1.84), hospitalisation (RR 1.35; 95% CI 1.17-1.57), emergency department attendance (RR 1.38; 95% CI 1.22-1.56), IBD-related surgery (RR 1.63; 95% CI 1.19-2.22), and a composite endpoint (RR 1.26; 95% CI 1.07-1.48).
  • In gut-to-brain analyses, clinically active disease at baseline predicted later anxiety (RR 2.24; 95% CI 1.25-4.01; n=249) and depression (RR 1.49; 95% CI 1.11-1.98; n=642).

## Methods

  • Systematic review and meta-analysis of longitudinal follow-up studies from EMBASE Classic, EMBASE, MEDLINE, and APA PsychInfo searched to July 11, 2021.
  • Included adult IBD studies with ≥50 participants, at least two follow-up time points separated by ≥6 months, and validated measures of anxiety/depression or IBD activity at baseline.
  • Pooled RRs and HRs using an inverse-variance random-effects model; heterogeneity was assessed with I² and the χ² test.

## Limitations

  • The paper states the evidence was limited by a relatively small number of eligible studies, variable quality, and significant heterogeneity in some analyses; it also notes too few studies to explore sources of heterogeneity or to assess publication bias.
  • The authors state that many studies had short follow-up (four had 12 months or less), which may be too brief for some endpoints.
  • Evident from the text: all eligible studies were conducted in hospital settings and mostly in North America, Europe, or Australia, so the findings may not generalize to community settings or other regions; the paper also says data were insufficient to compare effects by Crohn’s disease vs ulcerative colitis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2021-325985

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 8 Not valid · 21 Not checked · 54 Own results and interpretations

54 more claims · 8 with their cited sources checked

Create a free account to see all 91 claims and to verify the 57 references still open.

See all claims — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 21

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

See all 225

Metadata

Authors
Fairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C.
Affiliations
  • University of Leeds (GB)
  • St James's University Hospital (GB)
  • University of Padua (IT)
  • McMaster University (CA)
Corresponding author
Ford, Alexander C
Venue
Gut
Publisher
BMJ
Published
2021-11-01
Volume
71
Issue
9
Pages
1773-1780
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W3209431709
Cited by
225
References
49
Citations by year
2026: 48 · 2025: 66 · 2024: 55 · 2023: 39 · 2022: 16 · 2021: 1
FWCI
4.15
Type
journal article
Language
en
Open access
closed
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
gut-brain axis, inflammatory bowel disease, anxiety, depression, bidirectional effects, disease flares, treatment escalation, hospitalization, emergency department visits, prognosis, psychoneuroimmunology, gut microbiota, neuroimmune interactions, neuroinflammation
MeSH terms
Brain-Gut Axis, Anxiety, Follow-Up Studies, Humans, Prognosis, Inflammatory Bowel Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/gutjnl-2021-325985
The paper
Fairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C. (2022). Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis. Gut. https://doi.org/10.1136/gutjnl-2021-325985

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.